NASDAQ:AVTX

Avalo Therapeutics (AVTX) Earnings Date, Estimates & Call Transcripts

$3.10

+0.21 (+7.27%)

(As of 06/5/2023 ET)

Compare

Today's Range: $2.86
▼
$3.46
50-Day Range: $1.61
▼
$3.40
52-Week Range: $1.41
▼
$7.41

Volume: 1.29 million shs
Average Volume: 48,879 shs
Market Capitalization: $40.92 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $15.50

Upcoming Earnings Date: Aug. 3Estimated
Actual EPS (Mar. 29): -$1.04 Missed By -$0.52
Consensus EPS (Mar. 29): -$0.52
Last Year's Q4 EPS (11/9/2021): -$2.04

Earnings Per Share Revenue

AVTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AVTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Avalo Therapeutics Analyst Forecasts

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2023	1	($0.97)	($0.97)	($0.97)
Q2 2023	1	($1.12)	($1.12)	($1.12)
Q3 2023	1	($1.36)	($1.36)	($1.36)
Q4 2023	1	($1.55)	($1.55)	($1.55)
FY 2023	4	($5.00)	($5.00)	($5.00)

AVTX Earnings Date and Information

Avalo Therapeutics last issued its earnings results on March 29th, 2023. The reported ($1.04) EPS for the quarter, missing analysts' consensus estimates of ($0.52) by $0.52. The business had revenue of $0.90 million for the quarter, compared to analyst estimates of $5.20 million. Avalo Therapeutics has generated ($2.93) earnings per share over the last year (($2.93) diluted earnings per share). Earnings for Avalo Therapeutics are expected to grow in the coming year, from ($3.13) to ($2.13) per share. Avalo Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 3rd, 2023 based off prior year's report dates.

Avalo Therapeutics Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/3/2023 (Estimated)
5/4/2023	Q1 2023	($0.97)	($0.85)	+$0.12	($0.85)	$1.00 million	$0.48 million
3/29/2023	Q4 2022	($0.52)	($1.04)	($0.52)	($1.04)	$5.20 million	$0.90 million
11/7/2022	Q3 2022	($1.03)	$0.34	+$1.37	$0.34	$1.40 million	$14.95 million
8/4/2022	Q2 2022	($1.80)	($1.38)	+$0.42	($1.38)		$1.03 million
5/5/2022	Q1 2022	($0.14)	($0.20)	($0.06)	($0.20)		$1.17 million
3/2/2022	12/31/2021	($1.80)	($1.92)	($0.12)

11/9/2021	9/30/2021	($2.16)	($2.04)	+$0.12	($0.17)		$1.35 million
8/2/2021	Q2 2021	($2.16)	($2.16)		($0.18)		$3.36 million
5/13/2021	Q1 2021	($2.76)	($3.84)	($1.08)	($0.32)		$0.47 million
11/9/2020	Q3 2020	($1.20)	($1.92)	($0.72)	($0.15)	$1.50 million	$1.11 million
8/6/2020	Q2 2020	($1.20)	($1.80)	($0.60)	($0.11)	$2.25 million	$1.34 million
5/7/2020	Q1 2020	($1.44)	($0.48)	+$0.96	$0.26	$2.25 million	$2.75 million
11/14/2019	Q3 2019	($2.04)	($0.84)	+$1.20	($0.07)	$5.15 million	$5.61 million
8/8/2019	Q2 2019	($1.92)	($1.56)	+$0.36	($0.15)	$5.28 million	$4.45 million
5/9/2019	Q1 2019	($1.92)	($1.56)	+$0.36	($0.13)	$4.85 million	$5.41 million
11/13/2018	Q3 2018	($1.44)	($3.12)	($1.68)	$0.19	$4.80 million	$4.08 million
8/9/2018	Q2 2018	($1.20)	($1.20)		($0.01)	$4.50 million	$4.79 million
5/11/2018	Q1 2018		($0.84)	($0.84)	($0.02)		$4.48 million
4/2/2018	Q4 2017		($1.32)	($1.32)	($0.11)		$2.23 million
11/6/2017	Q3 2017	($2.88)	$6.24	+$9.12	$0.52		$25.04 million
8/14/2017	Q2 2017	($3.12)	($1.68)	+$1.44	($0.14)		$0.16 million
5/9/2017	Q1 2017	($3.48)	($2.28)	+$1.20	($0.19)		$0.38 million
3/14/2017	Q4 2016	($7.80)	($2.16)	+$5.64	($0.18)	$0.40 million	$0.18 million
11/8/2016	Q3 2016	($5.88)	($8.40)	($2.52)	($0.70)	$0.65 million	$0.32 million
8/15/2016	Q2 2016	($6.72)	($4.92)	+$1.80	($0.41)		$0.65 million
5/16/2016	Q1 2016	($4.68)	($7.08)	($2.40)	($0.59)
3/23/2016	Q4 2015		($6.36)	($6.36)	($0.53)
11/13/2015	Q3 2015		($1.80)	($1.80)	($0.15)

Avalo Therapeutics Earnings - Frequently Asked Questions

When is Avalo Therapeutics's earnings date?: Avalo Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 3rd, 2023 based off last year's report dates. Learn more on AVTX's earnings history.
Did Avalo Therapeutics beat their earnings estimates last quarter?: In the previous quarter, Avalo Therapeutics (NASDAQ:AVTX) missed the analysts' consensus estimate of ($0.52) by $0.52 with a reported earnings per share (EPS) of ($1.04). Learn more on analysts' earnings estimate vs. AVTX's actual earnings.

How much revenue does Avalo Therapeutics generate each year?: Avalo Therapeutics (NASDAQ:AVTX) has a recorded annual revenue of $17.35 million.
How much profit does Avalo Therapeutics generate each year?: Avalo Therapeutics (NASDAQ:AVTX) has a recorded net income of -$41.66 million. AVTX has generated -$2.93 earnings per share over the last four quarters.
What is Avalo Therapeutics's EPS forecast for next year?: Avalo Therapeutics's earnings are expected to grow from ($3.13) per share to ($2.13) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:AVTX) was last updated on 6/6/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Avalo Therapeutics (AVTX) Earnings Date, Estimates & Call Transcripts

AVTX Earnings Estimates and Actuals by Quarter

AVTX Estimated and Actual Revenue by Quarter

Avalo Therapeutics Analyst Forecasts

AVTX Earnings Date and Information

Avalo Therapeutics Earnings History by Quarter

Avalo Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info

Avalo Therapeutics (AVTX) Earnings Date, Estimates & Call Transcripts

Earnings Summary

AVTX Earnings Estimates and Actuals by Quarter

AVTX Estimated and Actual Revenue by Quarter

Avalo Therapeutics Analyst Forecasts

AVTX Earnings Date and Information

Avalo Therapeutics Earnings History by Quarter

Avalo Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat